Drugs and the FDA
Safety, Efficacy, and the Public's Trust
(Sprache: Englisch)
"The tension between the drugs patients need & what is necessary to demonstrate safety & efficacy; a story of hope in justifiably desperate patients vs. the time it takes to prove drugs actually work"--]cProvided by publisher.
Leider schon ausverkauft
versandkostenfrei
Taschenbuch
27.50 €
13 DeutschlandCard Punkte
sammeln
- Lastschrift, Kreditkarte, Paypal, Rechnung
- Kostenlose Rücksendung
Produktdetails
Produktinformationen zu „Drugs and the FDA “
Klappentext zu „Drugs and the FDA “
"The tension between the drugs patients need & what is necessary to demonstrate safety & efficacy; a story of hope in justifiably desperate patients vs. the time it takes to prove drugs actually work"--]cProvided by publisher.
Autoren-Porträt von Mikkael A. Sekeres
Mikkael A. Sekeres is Professor of Medicine and Chief of the Division of Hematology at the Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, and former Chair of the Oncologic Drugs Advisory Committee of the FDA. A regular contributor to the Well section of the New York Times, he is the author of When Blood Breaks Down: Life Lessons from Leukemia (MIT Press).
Bibliographische Angaben
- Autor: Mikkael A. Sekeres
- 2024, 320 Seiten, Maße: 15,2 x 22,9 cm, Taschenbuch, Englisch
- Verlag: The MIT Press
- ISBN-10: 0262548399
- ISBN-13: 9780262548397
- Erscheinungsdatum: 06.02.2024
Sprache:
Englisch
Kommentar zu "Drugs and the FDA"
0 Gebrauchte Artikel zu „Drugs and the FDA“
| Zustand | Preis | Porto | Zahlung | Verkäufer | Rating |
|---|
Schreiben Sie einen Kommentar zu "Drugs and the FDA".
Kommentar verfassen